Band 1
Provided by Jianwei Zhang
Mr. Zhang acts as the Managing Partner of JunHe, Shenzhen Office. He has been worked for JunHe since 2000, and during 2007 and 2008, he worked at the Silicon Valley Office of Fenwick & West LLP as a visiting lawyer.
Mr. Zhang’s major practice areas include capital market, corporate and mergers & acquisitions (M&As), Private Equity/Venture Capital and certain other areas. He provided all-around legal services for various domestic and multinational enterprises in their M&As, reorganization, restructuring, IPOs, investments and financing projects. Mr. Zhang has ranked as a leading lawyer in capital market, corporate and commercial areas by Chambers Asian-Pacific guide for several years.
Mr. Zhang also acts as an arbitrator of South China International Economic and Trade Arbitration Commission (Shenzhen Court of International Arbitration), a member of China Venture Capital Association, a mediator of the Mediation Center of SCIA and a member of the Legal Committee of ICC Shenzhen.
Mr. Zhang is a member of the All China Lawyers Association and Shenzhen Lawyers Association.
Provided by Chambers
Zhang Jianwei is the managing partner of JunHe's Shenzhen office and has a longstanding reputation in the Guangdong market. He has a background in engineering and is highly regarded for his expertise in capital markets and private equity transactions.
张建伟律师是深圳分所的管理合伙人，在广东市场久负盛名。他拥有工程学背景，因在资本市场和私募股权交易领域的专业能力而受到高度认可。
Provided by Chambers
He is eminent and well known to be capable.
Zhang Jianwei is active in capital markets, particularly A-share work. He is quite renowned.
张律师活跃于资本市场，尤其是 A 股业务。他相当有名。
他非常优秀，而且很有名。
He is eminent and well known to be capable.
Zhang Jianwei is active in capital markets, particularly A-share work. He is quite renowned.
张律师活跃于资本市场，尤其是 A 股业务。他相当有名。
他非常优秀，而且很有名。
1 item provided by JunHe LLP
JunHe helps QuantumPharm become the first to list on HKEX under new Chapter 18C rules
On 13 June 2024, QuantumPharm Inc. was listed on the Main Board of the Hong Kong Stock Exchange. QuantumPharm is the first stock to be listed under Chapter 18C of the New Rules Governing the Listing of Specialized Technology Companies on the Hong Kong Stock Exchange.
JunHe helps QuantumPharm become the first to list on HKEX under new Chapter 18C rules
On 13 June 2024, QuantumPharm Inc. was listed on the Main Board of the Hong Kong Stock Exchange. QuantumPharm is the first stock to be listed under Chapter 18C of the New Rules Governing the Listing of Specialized Technology Companies on the Hong Kong Stock Exchange.
